Medical and lifestyle management of peripheral arterial disease
S. Parvar(South Australian Health and Medical Research Institute), Stephen J. Nicholls(Australian Centre for Heart Health), Joseph Dawson(Royal Adelaide Hospital), Robert Fitridge(Royal Adelaide Hospital)
Cited by 78
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k